Lexpos News

As part of our Funding & Reimbursement Shorts  series, Community Pharmacy England’s in-house Drug Tariff and funding experts have created a new video on disallowed items. Disallowed items are those that have not been passed for payment by the NHS Business Services Authority (NHSBSA). It is important that pharmacy teams understand what can be done avoid [...]

The post Funding & Reimbursement Shorts: Disallowed items appeared first on Community Pharmacy England.

The Department of Health and Social Care (DHSC) has issued a medicine supply notification for the following products: Rivastigmine 4.6mg/24hours transdermal patches Rivastigmine 9.5mg/24hours transdermal patches MSN/2025/062 Tier 3 – high impact Date of issue: 03/12/2025 Summary Rivastigmine 4.6mg/24hours and 9.5mg/24hours transdermal patches are in limited supply until w/c 15 December 2025. Rivastigmine 13.3mg/24hours transdermal [...]

The post Medicine Supply Notification: Rivastigmine 4.6mg/24hours and 9.5mg/24hours transdermal patches appeared first on Community Pharmacy England.

Community Pharmacy England met in London on 19th and 20th November, with Committee members considering preparations for the next round of Community Pharmacy Contractual Framework (CPCF) negotiations, ongoing financial pressures, winter readiness and other important matters. Closing the sector’s longstanding funding gap and addressing operational pressures remain the central focus of the Committee. There has [...]

The post Upcoming CPCF negotiations the focus at November meeting appeared first on Community Pharmacy England.

The NHSmail programme is being rebranded to NHS.net Connect. This change, announced previously, introduces a refreshed look and new features. Your existing NHS.net email address, login details, and helpdesk support will remain the same. Some NHS.net users will soon see a refreshed homepage and improved features designed to make communication across the NHS easier. The [...]

The post NHSmail becoming NHS.net Connect: New Launchpad homepage coming soon appeared first on Community Pharmacy England.

In recent months, Community Pharmacy England has received a number of concerns about EPS pharmacy nominations and re-nominations without patient consent, and wishes to remind pharmacy owners of the relevant Terms of Service requirements and the importance of patient choice of nominated pharmacy. Terms of Service The Terms of Service provide that a pharmacy owner [...]

The post Respecting Patient Choice for Pharmacy EPS Nominations appeared first on Community Pharmacy England.